Ken Moseley is CLO & VP at BELLICUM PHARMACEUTICALS, INC (BLCM). They have made 6 open-market trades across 1 company since 2015, most recently 2018-01-03.
CIK 0001358403
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BLCM | 2,054 | $2K |
Shares reported on the most recent Form 4, priced at the 2018-01-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BLCM | SELL | 2017-07-13 | 2017-07-17 | $12.26 | $339K | -4.3% | -33.5% | -14.1% |
| BLCM | SELL | 2016-09-23 | 2016-09-23 | $20.10 | $235K | +1.3% | -17.3% | -33.5% |
| BLCM | SELL | 2016-09-21 | 2016-09-23 | $20.10 | $472K | +1.3% | -17.3% | -33.5% |
| BLCM | SELL | 2016-09-16 | 2016-09-20 | $20.01 | $70K | +0.5% | -16.6% | -25.6% |
| BLCM | SELL | 2016-08-15 | 2016-08-17 | $20.00 | $20K | -8.2% | +5.2% | +18.2% |
| BLCM | SELL | 2016-06-02 | 2016-06-06 | $13.00 | $195K | -5.5% | +4.4% | +32.4% |
| BLCM | SELL · 10b5-1 | 2015-11-02 | 2015-11-04 | $13.00 | $195K | -35.2% | -2.7% | -43.7% |
| BLCM | SELL · 10b5-1 | 2015-07-01 | 2015-07-06 | $20.62 | $309K | -35.2% | -2.7% | -2.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.